We previously demonstrated that CD34+ cells from PMF patients uniquely expressed CCR2 which, by contrast, is nearly absent on CD34+ cells from healthy subjects and other MPN subtypes (23). This evidence concerns the gene CCR2 and myeloproliferative neoplasm.